
Divi’s Laboratories Investor Relations Material
Latest events

Q4 24/25
Divi’s Laboratories
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Divi’s Laboratories Limited
Access all reports
Divi’s Laboratories Limited manufactures active pharmaceutical ingredients (APIs), intermediates, and nutraceutical ingredients for global pharmaceutical companies. The company specializes in custom synthesis and contract manufacturing for generic and branded drugs. Divi’s Laboratories serves customers in regulated markets including the United States and Europe. The company is headquartered in Hyderabad, India, and its shares are listed on the NSE.
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
DIVISLAB
Country
🇮🇳 India